Skip to content

Role of Virechan Karma(a Panchkarma procedure)in management of Psoriasis.

An analytical study on role of Virechan Karm in management of Psoriasis (Ek-kustha) with special reference to Prakriti - ASVPP

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/01/030621
Enrollment
30
Registered
2021-01-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified

Interventions

Intervention1: VIRECHAN KARM & SHAMAN CHIKITSA: The intervention will be given as Shamana Chikitsa and Shodhana with Shamana. Shamana Chikitsa inlcudes Panchtikta ghrit guggulu in a dose of 2 vati(eac

Sponsors

BANARAS HINDU UNIVERSITY
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age group: 18- 40 years of either sex as this age group is more prone for psoriasis. 2. Diagnosed cases of Psoriasis with H/O 1year onset of disease. 4. Patients willing to participate in study by giving their informed consent. 5. Mild to moderate cases of Psoriasis assessed using PASI scoring. 6. Psoriatic Patients who did not receive any systemic therapy/ phototherapy/ external application for the last 3 months

Exclusion criteria

Exclusion criteria: 1. Patients of age less than 18 and more than 40 yrs. 2. H/O any other Auto Immune diseases. 3. Patient under concomitant therapy for other Systemic diseases. 4. Patients with developed co-morbidities like Psoriatic arthritis. 6. Patient unfit for Virechan karm like pregnant and lactating women etc. 7. Patient not willing to participate by giving their informed consent.

Design outcomes

Primary

MeasureTime frame
PASI scoring Timepoint: Two months

Secondary

MeasureTime frame
Prakriti Agni Kostha StressTimepoint: unpredictable

Countries

India

Contacts

Public ContactDr Vandana Verma

Banaras Hindu University

vandana.verma04@gmail.com8840871859

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026